Evidence map›Paper›PMID 42336842›Full record

ArticleCell death & disease2026

YIF1A activates mTORC1 signaling to promote cellular senescence.

Xiaogang Zhang, Luying Liu, Mengdi Shang, Bin Hu, Shu Zhu, Xi Wang, Jieying Liu, Yanchun Han, Xiaodan Wei, Qi Cao and 8 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Xiaogang Zhang *School of Special Education and Rehabilitation, Shandong Medical and Pharmaceutical University, Yantai, China.
Luying Liu *School of Life Sciences and Health, University of Health and Rehabilitation Sciences, Qingdao, China.
Mengdi Shang *Peninsular Cancer Center, Shandong Medical and Pharmaceutical University, Yantai, China.
Bin Hu *The First School of Clinical Medicine, Shandong Medical and Pharmaceutical University, Binzhou, China.
Shu ZhuInstitute of Science and Technology Planning and Foresight, Chinese Academy of Science and Technology for Development, Beijing, China.
Xi WangSchool of Basic Medical, Shandong Medical and Pharmaceutical University, Yantai, China.
Jieying LiuSchool of Life Sciences and Health, University of Health and Rehabilitation Sciences, Qingdao, China.
Yanchun HanSchool of Basic Medical, Shandong Medical and Pharmaceutical University, Yantai, China.
Xiaodan WeiSchool of Basic Medical, Shandong Medical and Pharmaceutical University, Yantai, China.
Qi CaoSchool of Nursing, Zibo Polytechnic University, Zibo, China.
Fan LiSchool of Basic Medical, Shandong Medical and Pharmaceutical University, Yantai, China.
Lijie GaoKey Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Jingyu SunKey Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0009-0002-3452-9714
Jiaqi YuThe Second Medical College, Shandong Medical and Pharmaceutical University, Yantai, China.
Chentai TanThe Second Medical College, Shandong Medical and Pharmaceutical University, Yantai, China.
Menghua DongSchool of Basic Medical, Shandong Medical and Pharmaceutical University, Yantai, China. dmh2006@126.com.ORCID http://orcid.org/0009-0003-0904-4245
Tie-Shan TangKey Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. tangtsh@ioz.ac.cn.ORCID http://orcid.org/0000-0001-8975-6338
Jiu-Qiang WangPeninsular Cancer Center, Shandong Medical and Pharmaceutical University, Yantai, China. wangjiuqiang1007@sdmpu.edu.cn.ORCID http://orcid.org/0000-0002-0313-2012

Funding

National Natural Science Foundation of China (National Science Foundation of China) 2023YFA1801904Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2020QH066Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2023QH126
6 · The paper itself

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) serves as a central metabolic hub that integrates nutrient signals and orchestrates cellular metabolism to regulate many fundamental cell processes. While mTORC1 activation is known to occur both on lysosomal membranes and at the Golgi apparatus in response to environmental cues, the molecular mechanisms governing its Golgi-associated activation remain poorly understood. In this study, we identified YIF1A as a novel Golgi-localized regulator of growth factor-mediated mTORC1 signaling. Mechanistically, YIF1A interacted with the E3 ubiquitin ligase RNF126 to facilitate K48-linked polyubiquitination of G3BP1/2, thereby promoting mTORC1 activation. Genetic depletion of either YIF1A or RNF126 stabilized G3BP1/2 proteins and significantly impaired mTORC1 activity. Notably, YIF1A knockdown conferred resistance to etoposide- and doxorubicin-induced cellular senescence. The evolutionary conservation of this pathway was demonstrated by extended or shortened lifespan in Caenorhabditis elegans lacking or overexpressing yif-1, the invertebrate ortholog of YIF1A. Our findings not only elucidate a previously unrecognized Golgi-specific regulatory axis for mTORC1 activation but also suggest YIF1A as a potential therapeutic target for modulating aging-related pathologies.

Indexed as

Caenorhabditis elegans ProteinsCellular SenescenceMechanistic Target of Rapamycin Complex 1Vesicular Transport ProteinsAnimalsCaenorhabditis elegansDoxorubicinEtoposideGolgi ApparatusHEK293 CellsHumansMultiprotein ComplexesSignal TransductionUbiquitinationUbiquitin-Protein LigasesCaenorhabditis elegans ProteinsDoxorubicinEtoposideMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesUbiquitin-Protein LigasesVesicular Transport Proteins

Identifiers

PMID42336842
PMCPMC13542221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.